Sarissa Capital Management as of June 30, 2020
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 12 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 19.1 | $172M | 643k | 267.55 | |
| Alkermes SHS (ALKS) | 16.9 | $152M | 7.8M | 19.41 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 16.1 | $145M | 14M | 10.32 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 11.4 | $102M | 928k | 110.34 | |
| Innoviva (INVA) | 10.0 | $90M | 6.4M | 13.98 | |
| Alexion Pharmaceuticals | 9.3 | $83M | 744k | 112.24 | |
| Mersana Therapeutics (MRSN) | 6.7 | $60M | 2.6M | 23.40 | |
| Intercept Pharmaceuticals In | 6.4 | $58M | 1.2M | 47.91 | |
| Abbvie (ABBV) | 3.4 | $30M | 310k | 98.18 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $5.1M | 1.1M | 4.76 | |
| Regulus Therapeutics Com New | 0.1 | $1.3M | 1.9M | 0.68 | |
| Mirati Therapeutics | 0.0 | $114k | 1.0k | 114.00 |
